VBI Vaccines Inc. [VBIV] stock prices are up 111.29% to $0.13 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VBIV shares have gain 7.18% over the last week, with a monthly amount drifted -82.34%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
VBI Vaccines Inc. [NASDAQ: VBIV] stock has seen the most recent analyst activity on November 11, 2022, when Raymond James downgraded its rating to a Outperform and also revised its price target to $2 from $5. On February 25, 2021, Jefferies initiated with a Buy rating and assigned a price target of $7 on the stock. Raymond James upgraded its rating to a Strong Buy and increased its price target to $9 on August 27, 2020. Oppenheimer initiated its recommendation with a Outperform and recommended $9 as its price target on January 16, 2019. Canaccord Genuity started tracking with a Buy rating for this stock on November 01, 2017, and assigned it a price target of $10. In a note dated October 10, 2016, Laidlaw initiated an Buy rating and provided a target price of $6 on this stock.
The stock price of VBI Vaccines Inc. [VBIV] has been fluctuating between $0.06 and $1.35 over the past year. VBI Vaccines Inc. [NASDAQ: VBIV] shares were valued at $0.13 at the most recent close of the market.
Analyzing the VBIV fundamentals
The VBI Vaccines Inc. [NASDAQ:VBIV] reported sales of 9.41M for trailing twelve months, representing a surge of 150.31%. Gross Profit Margin for this corporation currently stands at -0.29% with Operating Profit Margin at -7.56%, Pretax Profit Margin comes in at -8.82%, and Net Profit Margin reading is -8.82%. To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is -10.82 and Total Capital is 33.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -9.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.0933 points at the first support level, and at 0.0536 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1993, and for the 2nd resistance point, it is at 0.2656.
Ratios To Look Out For
It’s worth pointing out that VBI Vaccines Inc. [NASDAQ:VBIV]’s Current Ratio is 0.34. As well, the Quick Ratio is 0.21, while the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 0.41.
